8-K - Bio Green Med Solution, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Bio Green Med Solution reported Q4 and full year 2025 financial results with $0.7M fire safety revenue post-Fitters acquisition, reduced net loss to $3.0M from $11.2M, and $3.5M cash runway into Q3 2026.

Key Takeaways

1Acquired Fitters Sdn. Bhd. on Sep 12, 2025, generating $0.7M product revenue for Q4 and FY2025.

2Cash and equivalents at $3.5M as of Dec 31, 2025, sufficient into Q3 2026.

3FY2025 net loss $3.0M vs $11.2M in 2024, driven by $4.9M gain on UK subsidiary deconsolidation.

4R&D expenses dropped to $0.8M from $6.7M after liquidating Cyclacel Limited and selling plogosertib.

5Sold plogosertib assets for $300K plus $170K potential milestone in October 2025.

6Declared $0.15/share dividend on 6% Convertible Preferred Stock, paid Feb 1, 2026.

Current Report Details

Event Type

Financial Results

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. ** The information set forth under this “Item 2.02. Results of Operations and Financial Condition,” including the

Financial Results

7.01

. Regulation FD Disclosure. ** The information set forth in Item 2.02 of this Current Report on Form 8-K is hereby incorporated by reference. A copy of the pres

Regulation Fd

9.01

. Financial Statements and Exhibits. ** (d) Exhibits. | Exhibit No. | | Exhibit | |---|---|---| | 99.1 | | Press release announcing financial results for Bio Gr

Exhibits Only

Source Document

Capital Return

Dividend/Share

0.15

Record Date

2026-01-22

Payable Date

2026-02-01

Exhibits (2)

8-K

99.1

EX-99.1